Epithelial-mesenchymal plasticity of breast cancer stem cells: implications for metastasis and therapeutic resistance
about
Aggressiveness Niche: Can It Be the Foster Ground for Cancer Metastasis Precursors?Giant obscurins regulate the PI3K cascade in breast epithelial cells via direct binding to the PI3K/p85 regulatory subunitComparison of the PI3KCA pathway in circulating tumor cells and corresponding tumor tissue of patients with metastatic breast cancer.Challenging a Misnomer? The Role of Inflammatory Pathways in Inflammatory Breast CancerPalmitoylation: a protein S-acylation with implications for breast cancer.Modeling of Cancer Stem Cell State Transitions Predicts Therapeutic Response.Ribosomal L22-like1 (RPL22L1) Promotes Ovarian Cancer Metastasis by Inducing Epithelial-to-Mesenchymal TransitionAn epithelial marker promoter induction screen identifies histone deacetylase inhibitors to restore epithelial differentiation and abolishes anchorage independence growth in cancers.Involvement of gelsolin in TGF-beta 1 induced epithelial to mesenchymal transition in breast cancer cells.Genome-wide gain-of-function screen for genes that induce epithelial-to-mesenchymal transition in breast cancerSelective expression of constitutively active pro-apoptotic protein BikDD gene in primary mammary tumors inhibits tumor growth and reduces tumor initiating cells.Murine mesothelin: characterization, expression, and inhibition of tumor growth in a murine model of pancreatic cancer.Glioblastoma: Defining Tumor Niches.An iTEP-salinomycin nanoparticle that specifically and effectively inhibits metastases of 4T1 orthotopic breast tumors.Primary cancer cell culture: mammary-optimized vs conditional reprogramming.Ubiquitin-specific protease 4 inhibits breast cancer cell growth through the upregulation of PDCD4A 22q11.2 amplification in the region encoding microRNA-650 correlates with the epithelial to mesenchymal transition in breast cancer primary cultures of Mexican patients.Downregulation of miRNA-141 in breast cancer cells is associated with cell migration and invasion: involvement of ANP32E targeting.Pterostilbene prevents AKT-ERK axis-mediated polymerization of surface fibronectin on suspended lung cancer cells independently of apoptosis and suppresses metastasis.Poor Prognosis Indicated by Venous Circulating Tumor Cell Clusters in Early Stage Lung Cancers.Roles and epigenetic regulation of epithelial-mesenchymal transition and its transcription factors in cancer initiation and progression.Breast cancer stem cell: the roles and therapeutic implications.Cancer stem cell-targeted therapeutics and delivery strategies.Recent progress on the effects of microRNAs and natural products on tumor epithelial-mesenchymal transition.Epithelial-mesenchymal transition: potential regulator of ABC transporters in tumor progression.HES1 Promotes Colorectal Cancer Cell Resistance To 5-Fu by Inducing Of EMT and ABC Transporter Proteins.Both bulk and cancer stem cell subpopulations in triple-negative breast cancer are susceptible to Wnt, HDAC, and ERα coinhibition.Metabolomic mapping of cancer stem cells for reducing and exploiting tumor heterogeneity.Protein tyrosine phosphatase receptor-type δ acts as a negative regulator suppressing breast cancer.Arachidonic Acid Metabolite as a Novel Therapeutic Target in Breast Cancer Metastasis.UNC0638, a G9a inhibitor, suppresses epithelial‑mesenchymal transition‑mediated cellular migration and invasion in triple negative breast cancer.Celecoxib targets breast cancer stem cells by inhibiting the synthesis of prostaglandin E2 and down-regulating the Wnt pathway activity.Fatty acid synthase (FASN) as a therapeutic target in breast cancer.Inhibition of N-acetyltransferase 10 using remodelin attenuates doxorubicin resistance by reversing the epithelial-mesenchymal transition in breast cancer.Nuclear Gli1 expression is associated with pathological complete response and event-free survival in HER2-positive breast cancer treated with trastuzumab-based neoadjuvant therapy.Cancer stem cells (CSCs): metabolic strategies for their identification and eradication.Personalized regulation of glioblastoma cancer stem cells based on biomedical technologies: From theory to experiment (Review).Cytokines, breast cancer stem cells (BCSCs) and chemoresistanceMiR-205-5p inhibition by locked nucleic acids impairs metastatic potential of breast cancer cellsThe Role of Biomaterials on Cancer Stem Cell Enrichment and Behavior
P2860
Q26738966-94556C5D-A308-4DBB-9EBF-756C7597DC65Q30008900-13054629-C487-41F4-AE03-8251ECDAF4B6Q33674656-F5F3C6ED-2860-4DF7-94C2-A583CE99E734Q33760216-3D41AB7E-333D-494C-A762-798CB0507277Q33915087-DBB0639E-6FD5-4013-9389-9EDA4D5D947CQ35784537-DE400EF3-DFBA-416B-B82E-73C026D0ADB7Q35855606-A36BC4DF-FF14-46BE-9A59-E5596F9E3E85Q36110047-04C0532E-AE9F-4828-B14E-B59773A8A74BQ36190070-429702D2-3E2E-4E9F-A68E-9A53F3273311Q36201682-4E0AD4AD-07B2-44F7-83F7-B42D7AB4E7EEQ36516589-EA3A5BAD-4A61-4D14-98DC-00EE60E6C13EQ36639456-0AECECFA-3C73-4732-B834-F06FEA2EDEC3Q36796616-F95246C6-88C6-43C8-A6D1-D0052E56BCD1Q36834993-FFF871E3-7222-41DD-BA09-4676AE936A9AQ37130539-367077D6-B1A1-47BB-8D40-18AE84723CC3Q37187508-43C5233D-3664-4154-B1DD-F6DBBBF7C7DEQ37588073-7B424B0B-3FF6-4ADF-AFCB-71ABCBF94958Q37693436-CB5467ED-937D-4E6F-8B88-B500C69F99E6Q37715844-63785439-3ADB-4288-9F89-E2DD08AEC1A0Q38431117-A85D52AA-7E27-4809-B84E-0B08E8FFCEB9Q38909048-AC7E8111-8148-49DA-B5A2-97C8F1884356Q38929036-4041D2AB-9159-44D6-84BF-4A6A2FBE6AC4Q39014576-30D2C142-A979-4608-A67C-00E5A263F2EBQ39458257-C1BABD90-25B6-419E-A1FC-3A5FE94E04E5Q41441070-B236EFAC-1DD3-4BEE-A74A-6075351F0DD0Q41721768-FDE92B95-CEA2-49FF-8381-A87EAFB9230DQ45416563-AD4573A3-CB83-4A7F-B145-676C952454AEQ47110103-D134C792-BD8B-4D41-9315-1B5A3D425AD4Q47152563-E9B2564E-B9A9-46FA-B490-61F6D72B2FF0Q47239487-DE800845-8594-4483-AE07-30A1883D984EQ47365430-1758E7CE-4399-4613-9B51-DE423A2BD4D5Q49271132-F7BF3524-970E-4997-894F-4EBCC69F77BBQ50044384-D0BC930B-235B-4074-93C0-4138D62CDB1AQ50105831-3DCE75B4-225A-4D40-BD8B-22CA449C61ABQ53291372-91D84CA6-5DEE-4E1A-9B5D-363B9BCA9AA7Q55254924-B285F824-FC5C-4913-994E-84F30436AEF2Q55509415-D4FF2160-F116-4769-82E5-7794E0BE275CQ57106445-AA5B733C-0EEE-4EC7-A82A-CA3B763BDD6AQ57174508-80EE959D-932F-4F6C-9368-B1F9806C06DAQ57584305-4D9A2945-AF80-4270-B3AE-F9A1601B3DA8
P2860
Epithelial-mesenchymal plasticity of breast cancer stem cells: implications for metastasis and therapeutic resistance
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Epithelial-mesenchymal plastic ...... sis and therapeutic resistance
@ast
Epithelial-mesenchymal plastic ...... sis and therapeutic resistance
@en
Epithelial-mesenchymal plastic ...... sis and therapeutic resistance
@nl
type
label
Epithelial-mesenchymal plastic ...... sis and therapeutic resistance
@ast
Epithelial-mesenchymal plastic ...... sis and therapeutic resistance
@en
Epithelial-mesenchymal plastic ...... sis and therapeutic resistance
@nl
prefLabel
Epithelial-mesenchymal plastic ...... sis and therapeutic resistance
@ast
Epithelial-mesenchymal plastic ...... sis and therapeutic resistance
@en
Epithelial-mesenchymal plastic ...... sis and therapeutic resistance
@nl
P2093
P2860
P1476
Epithelial-mesenchymal plastic ...... sis and therapeutic resistance
@en
P2093
P2860
P304
P356
10.2174/1381612821666141211120604
P407
P577
2015-01-01T00:00:00Z